|
Ellagic Acid may be one of the most potent
ways to prevent Cancer.
Ellagic Acid Background
Ellagic Acid, a phenolic compound, is a proven anti-carcinogen, anti-mutagen, and anti-cancer initiator.
Ellagic Acid - History of Cancer Prevention
Published research on ellagic acid appeared in the early 1970s. First true studies began in early 1990. However, folklore remedies involving phytochemical extracts fhave been around for
centuries.
Ellagic Acid - Evidence
Research indicates that Ellagic Acid slows the growth of abnormal colon
cells in humans, prevents the development of cells infected with human
papilloma virus (HPV) which is linked to cervical cancer, and promotes
apoptotic growth (natural death) of prostate cancer cells. The apoptotic
process, triggered by this antioxidant ellagitannin) also has beneficial
effects on breast, lung, esophageal, and skin cancer (melanoma). Medical
studies in Europe further show that ellagic acid reduces the occurrence
of birth defects, promotes wound healing, reduces and reverses chemically
induced liver fibrosis, and is helpful in the fight against heart disease.
Inhibition of carcinogenesis by Ellagic acid has been demonstrated in animals with oesophagus, tongue, lung, colon, liver, and skin tumors. Ellagic acid inhibits the initiation of tumors
through a number of mechanisms, including inhibition of metabolic activation of carcinogenic compounds (such as polycyclic hydrocarbons, nitroso-containing chemicals or food preservatives,
and aflatoxins) into forms that induce cell DNA damage.
|
Ellagic - Detailed
graph points of intervention
Ellagic -
Metabolic pathways of Ellagitannins
Ellagic
Acid - Background
Ellagic Acid -
History
Ellagic Acid -
Evidence
Ellagic Acid - Clinical
Studies
Ellagic Acid
- Mode of Action
Ellagic Acid -
Medical References
Ellagic Acid
- Med. References cont.
Ellagic Acid - Reference
Papers
General Health - Resources |
